FDA approves Teflaro for treatment of community-acquired bacterial pneumonia
Links shared publicly online about this topic.
- 816total visits
FDA approves Teflaro for treatment of community-acquired bacterial pneumonia
Forest Laboratories, Inc. announced today that Teflaro(ceftaroline fosamil), a broad-spectrum bactericidal cephalosporin with activity against both gram-positive and gram-negative microorganisms, was approved by the U.S. Food and Drug Administration (FDA) for the treatment of community-acquired bacterial pneumonia (CABP), including cases caused by Streptococcus pneumoniae bacteremia, and acute bacterial skin and skin structure infection (ABSSSI), including cases caused by methicillin-resistant S
View full resource at news-medical.net
Most Recently Shared on October 30, 2010 at 4:33 pm By:
FDA approves Teflaro for treatment of community-acquired bacterial pneumonia: Forest Laboratories, Inc. announced ... http://bit.ly/ci6Cqx
Advertisement
